Could DNA methylation become a useful measure for multiple myeloma prognoses?

被引：1

作者：

Walker, Brian A. ^{[1
]}

Morgan, Gareth J. ^{[1
]}

机构：

[1] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England

来源：

EXPERT REVIEW OF HEMATOLOGY | 2011年 / 4卷 / 02期

关键词：

DNA methylation; MGUS; myeloma; prognosis; MONOCLONAL GAMMOPATHY;

D O I：

10.1586/EHM.11.7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：125 / 127

页数：3

共 50 条

[41] Multiple myeloma will become a common cancer in the era of modern therapy
Rosenberg, Philip S.
Best, Ana
Anderson, William F.
Landgren, Ola
CANCER RESEARCH, 2016, 76
[42] Methylation of mitochondrial DNA is not a useful marker for cancer detection
Maekawa, M
Taniguchi, T
Higashi, H
Sugimura, H
Sugano, K
Kanno, T
CLINICAL CHEMISTRY, 2004, 50 (08) : 1480 - 1481
[43] Progression of multiple myeloma could be halted with multipeptide immunotherapy
Reeve, Emily
EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (01) : 14 - 14
[44] Progression of multiple myeloma could be halted with multipeptide immunotherapy
Reeve, Emily
IMMUNOTHERAPY, 2012, 4 (02) : 138 - 138
[45] Progression of multiple myeloma could be halted with multipeptide immunotherapy
Reeve, Emily
FUTURE ONCOLOGY, 2012, 8 (02) : 118 - 118
[46] Could Multiple Myeloma VEGF Modify the Systemic Microcirculation?
Cicco, S.
Ditonno, P.
Reale, A.
Savino, S.
Castrovilli, A.
Catacchio, I.
Ria, R.
Vacca, A.
OXYGEN TRANSPORT TO TISSUE XXXIII, 2012, 737 : 155 - 160
[47] Could mitogens be a new therapeutic intervention in multiple myeloma?
Spary, L. K.
Morse, H. R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 142 - 142
[48] Could mitogens be a new therapeutic intervention in multiple myeloma?
Spary, Lisa K.
Kemp, Kevin C.
Morse, H. Ruth
TOXICOLOGY, 2006, 226 (01) : 49 - 50
[49] Progression of multiple myeloma could be halted with multipeptide immunotherapy
Reeve, Emily
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 136 - 136
[50] Progression of multiple myeloma could be halted with multipeptide immunotherapy
Reeve, Emily
EXPERT REVIEW OF VACCINES, 2012, 11 (02) : 131 - 131

← 1 2 3 4 5 →